Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1993-12-29
1995-11-14
Scheiner, Toni R.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 71, 435 79, 435 794, 435 795, 436518, G01N 3353, G01N 33543, G01N 3368, C12Q 100
Patent
active
054665817
ABSTRACT:
The present invention provides an immunoassay method for screening for gram negative sepsis in a subject, in which the concentration of extracellular BPI in a plasma sample from the subject is determined and compared with a standard concentration of BPI indicative of gram negative sepsis.
REFERENCES:
patent: 5245013 (1993-09-01), Ulevitch et al.
Elsbach et al., "Separation and Purification of a Potent Bactericidal/Permeability-Increasing Protein and a Closely Associated Phospholipase A.sub.2 from Rabbit Polymorphonuclear Leukocytes," J. Biol. Chem., 254:11000-11009 (1979).
Gazzano-Santoro et al., "High-Affinity Binding of the Bactericidal/Permeability-Increasing Protein and a Recombinant Amino-Terminal Fragment to the Lipid A Region of Lipopolysaccharide," Infection and Immunity, 60(11):4754-4761 (1992).
Leturcq et al., "Generation of Monoclonal Antibodies to Human LBP and their Use in the Detection of LBP Protein in Serum," J. Cell. Biochem., 16C:161 (1992).
Pereira et al., "Quantitation of a Cationic Antimicrobial Granule Protein of Human Polymorphonuclear Leukocytes by ELISA," J. Immunol. Methods, 117:115-120 (1989).
Pesce et al., "Cationic Antigens--Problems Associated with Measurement by ELISA," Immunol. Methods, 87:21-27 (1986).
Schumann, et al., "Structure and Function of Lippopolysaccharide Binding Protein," Science, 249:1429-1431 (Sep. 21, 1990).
Weiss, et al., "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils," Blood, 69(2):652-659 (1987).
Weiss et al., "Human Bactericidal/Permeability-Increasing Protein and a Recombinant NH.sub.2 -Terminal Fragment Cause Killing of Serum-Resistant Gram-Negative Bacteria in Whole Blood and Inhibit Tumor Necrosis Factor Release Induced by the Bacteria," J. Clin. Invest., 90:1122-1130 (Sep., 1992).
Weiss et al., "Purification and Characterization of a Potent Bactericidal and Membrane Active Protein from the Granules of Human Polymorphonuclear Leukocytes," J. Biol. Chem., 253(8):2664-2672 (1978).
White, M. L. et al. J. Immunol. Methods 167:227-235, 1994.
Dofferhoff, A S M et al. Netherlands Journal of Medicine 39:45-62, 1991.
Spitznagel, J. K. J. Clin. Invest. 86:1381-1386, 1990.
Schindler, R. et al. Clinical Nephrology 40(6):346-351, 1993.
Taber, C. W. Taber's Cyclopedic Medical Dictionary. Philadelphia; F. A. Davis Co., 1985. p. 545.
Marra, M. N., et al. J. of Immunol. 148:532-537, 1992.
Erwin, A. L. et al. Laboratory Investigation 65(2) 138-144, 1991.
Von der Mohier et al. Abstract presented at the 13th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, Mar. 1993.
Carroll Stephen F.
Ma Jeremy K.-k.
White Mark L.
Scheiner Toni R.
Wilson Eve J.
Xoma Corporation
LandOfFree
Method for quantifying BPI in body fluids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for quantifying BPI in body fluids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for quantifying BPI in body fluids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220288